Massimo L’Andolina

Statistics

Publications

Citations

329

H-Index

Active since

2018

Affiliations

Azienda Ospedaliera di Cosenza(Current)

University of Florence

University of Pisa

University of Modena and Reggio Emilia

Ospedale Maggiore

Massimo L’Andolina is an author at Azienda Ospedaliera di Cosenza specializing in systemic autoimmune disease association, infectious diseases, and immunopathology.

ORCID

Publications per year

2018–2021

Publications

COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series

Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo et al. · Clinical Rheumatology · 2020 · 148 citations · Full text

Life Sciences, Immunology, Internal Medicine +11

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups

Clodoveo Ferri, Francesco Ursini, Laura Gragnani et al. · Journal of Autoimmunity · 2021 · 122 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study

Dilia Giuggioli, Valeria Riccieri, Elisabetta Zanatta et al. · The Lancet Rheumatology · 2021 · 32 citations · Full text

Veterinary Medicine, Infectious Diseases, Disease Surveillance +9

Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments

Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo et al. · Current Pharmaceutical Design · 2021 · 15 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)

Caterina Palleria, Luigi Francesco Iannone, Christian Leporini et al. · PLoS ONE · 2018 · 12 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacology +17

1–5 of 5